|
CODX | Co-Diagnostics, Inc. |
| Surgical & Medical Instruments & Apparatus |
| Book value per $ invested | $ 3.72 |
| Leverage | 10.98% |
| Market Cap | $ 10.7m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -32.1m |
| Margin | -1185.72% |
Co-Diagnostics, Inc., a molecular diagnostic company, develops, manufactures, and sells reagents used for diagnostic tests that function by detecting and / or analyzing nucleic acid molecules. The company is headquartered in Salt Lake City, Utah.